SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 24.640.0%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Fuzzy7/28/2015 10:38:57 AM
   of 9523
 
PFE---Reports Q2 (Jun) earnings of $0.56 per share, excluding non-recurring items, $0.04 better than the Capital IQ Consensus Estimate of $0.52; revenues fell 7.2% year/year to $11.85 bln vs the $11.42 bln consensus, which reflects operational growth of $125 million, or 1%, more than offset by the unfavorable impact of foreign exchange of $1.0 billion, or 8%. Excluding the impact of foreign exchange, adjusted diluted EPS(2) increased by approximately 6%. Co issues in-line guidance for FY15, raises EPS to $2.01-2.07, excluding non-recurring items, from $1.95-2.05 vs. $2.06 Capital IQ Consensus; raises FY15 revs to $45-46 bln from $44-46 bln vs. $45.96 bln Capital IQ Consensus Estimate.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext